US Patent 9550002 Phospholipid analogs as diapeutic agents and methods thereof
Patent 9550002 was granted and assigned to Cellectar on January, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9550002 Phospholipid analogs as diapeutic agents and methods thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
